Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 41 min ago
Peer-reviewedCC BY-NC-NDTranslational lung cancer research

Small-molecule inhibitors and checkpoint inhibitors in KRAS G12C NSCLC: balancing efficacy and toxicity.

  • Emma D A Wagener1
  • Anneloes L Noordhof2
  • Wouter H van Geffen1
  1. 1Department of Pulmonary Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands.
  2. 2Frisius Medical Centre, Leeuwarden, The Netherlands.
Read full textPDFDOICite

Related

  1. Efficacy of anlotinib plus immune checkpoint inhibitors in soft-tissue sarcoma: systematic review and meta-analysis
    Ahmed Farid Gadelmawla, Ahmed A. Abo Elnaga, Abdullah Faisal Albukhari +10
    Future OncologyPeer-reviewedLicence not statedFull textClinical trials & evidence synthesisPMC
  2. Efficacy and Safety of Immune Checkpoint Inhibitors for Lung Cancer Complicated by Interstitial Pneumonia: The CS-Lung 003 Study, Branch Number 28.
    Kosuke Hamai, Nobuhiro Kanaji, Naoki Watanabe +12
    Thoracic cancerPeer-reviewedCC BYFull textOncologyEurope PMC
  3. Efficacy and Safety of Sequential Radiotherapy and Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Single-Center PSM Retrospective Cohort Study.
    Huaxi Fan, Rong Yu, Guishu Wu +6
    Journal of hepatocellular carcinomaPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
  4. Efficacy and safety of immune checkpoint inhibitors combined with TKIs for recurrent or metastatic cervical cancer with PIK3CA mutation
    Lele Chang, Yaxin Kang, Mingxuan Zhu +3
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  5. Efficacy and safety of stereotactic body radiotherapy combined with immune checkpoint inhibitors for non-small cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis.
    Pengfei Ji, Zhihui Zhao, Xinpu Tang +7
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{wagener2026smallmolecule,
  title = {{Small-molecule inhibitors and checkpoint inhibitors in KRAS G12C NSCLC: balancing efficacy and toxicity.}},
  author = {Emma D A Wagener and Anneloes L Noordhof and Wouter H van Geffen},
  journal = {Translational lung cancer research},
  year = {2026},
  month = oct,
  doi = {10.21037/tlcr-2026-1012},
  url = {https://europepmc.org/article/MED/42999652},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Small-molecule inhibitors and checkpoint inhibitors in KRAS G12C NSCLC: balancing efficacy and toxicity.
AU  - Emma D A Wagener
AU  - Anneloes L Noordhof
AU  - Wouter H van Geffen
PY  - 2026
DA  - 2026/10/22
JO  - Translational lung cancer research
DO  - 10.21037/tlcr-2026-1012
UR  - https://europepmc.org/article/MED/42999652
SN  - 2218-6751
SN  - 2226-4477
ER  -